Podcast: Play in new window | Download
Subscribe: Google Podcasts | RSS
Ini Afia is the Chief Science Officer at Cannasafe, a licensed cannabis testing lab in southern California. He has also set up multiple labs with best-in-class methodology, processes, and technology throughout his career. And at Cannasafe he has the team towards greater credibility, consistency, and accountability for their clients, regulators, and consumers.
Ini returns to the podcast to discuss the push to standardize cannabis testing labs in California.
In late November, the California Department of Cannabis Control issued a statement that they are planning to standardize operating procedures and methods for California cannabis labs by January 2023. This announcement got a mixed reaction. On the one hand, consumers and producers, who have expressed frustration with inconsistencies in lab results, welcomed the idea. However, many laboratory professionals were quick to point out that it’s easier said than done. Especially because the state didn’t offer much insight into what exactly the DCC would standardize or how they would do it.
During the conversation we discuss :
- Why lab standardization is a good idea
- The problem of lab shopping
- Why some labs intentionally inflate THC values
- How natural variations in the cannabis plant can create a range of potency results
- How mishandling certified reference materials can throw off lab results
- Why labs need to be more transparent with their measurement of uncertainty
- Whether standardization will stifle lab innovation which is so important in an emerging industry
Thank You to This Episode’s Sponsor: Cannasafe
CannaSafe is a California-based cannabis analytical testing lab paving the way in the industry through research, education, and social equity efforts. Championing safe and effective cannabis, hemp, and CBD for all, one test at a time.
Learn more at csalabs.com
Additional Resources